Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer Genetics
New data from Medical College of Georgia, Department of Surgery illuminate research in breast cancer genetics
March 13th, 2008
Researchers detail in 'Breast cancer cell-derived fibroblast growth factor 2 and vascular endothelial growth factor are chemoattractants for bone marrow stromal stem cells,' new data in breast cancer. "Recent efforts by the scientific community to characterize the complex interplay between different cell types involved in the development of tumors have led us to investigate the roles of vascular endothelial growth factor (VEGF) and fibroblast growth factor 2 (FGF2) in the development of breast cancer. Using modified Boyden chamber assays, we measured the in vitro migration effect on murine mesenchymal stem cells (MSCs)," scientists writing in the journal Annals of Surgery...
Source: Women's Health Weekly (2008-03-13)
|
